Olema Pharmaceuticals, Inc.
- OLMA
- NASDAQ
- Biotechnology
- Women's Oncology Therapeutics
$7.08
Today +7.52%Quote Oct 19, 2026, 04:54 PM UTC
−33.54%over the last month
Max drawdown −33.5%From 1-month high −33.5%3 months −42.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Olema Pharmaceuticals
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
150
Market value
$619.0M
Quote Oct 19
Floor
$6.75
4.6% below price
Resistance
$7.15
1.1% above price
Price vs analyst targets
9 analysts
Lowest target
$20.00Highest target
$35.00
$20.00Highest target
$35.00
- Price $7.08
- Average target $28.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 300% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OLMAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free